tirzepatide and retatrutide Navigating the Weight Loss Maze: vs. Tirzepatide NOW or Wait for

LBA 43 Rnnbck, C

[DOI] [PMC free article] [PubMed] [Google Scholar] 55.Umapathysivam M.M., Lee M.Y., Jones K.L., Annink C.E., Cousins C.E., Trahair L.G., Rayner C.K., Chapman M.J., Nauck M.A., Horowitz M., et al

Users of Ozempic often see modest weight loss within the first month

A 2014 study in the Journal of Neuroscience found that activating spinal GLP-1 receptors specifically suppressed pain hypersensitivity via spinal microglia [7]

CVSs decision to drop Tirzepatide from its formulary may be more than just a business call it could be a sign of broader changes in how weight loss drugs will be managed by insurers and PBMs

While GLP-1s are reshaping obesity and diabetes care, the medical technology sector continues to benefit from broader healthcare trends